In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii | Zendy

Remedios Guna | Zendy; Carlos Muñoz | Zendy; Victoria Domínguez | Zendy; Ángeles García-García | Zendy; Jorge Gálvez | Zendy; Jesús Vicente de Julián-Ortiz | Zendy; Rafael Borrás | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii

Author(s) -

Remedios Guna,

Carlos Muñoz,

Victoria Domínguez,

Ángeles García-García,

Jorge Gálvez,

Jesús Vicente de Julián-Ortiz,

Rafael Borrás

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki111

Subject(s) - mycobacterium kansasii , moxifloxacin , linezolid , microbiology and biotechnology , clarithromycin , medicine , mycobacterium , antibacterial agent , in vitro , antibiotics , virology , biology , bacteria , staphylococcus aureus , tuberculosis , vancomycin , pathology , genetics , biochemistry

To compare the activity of linezolid with a range of drugs used in the treatment of Mycobacterium kansasii infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research